Cargando…
Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA
BACKGROUND: Despite having unquestionable glucose lowering efficacy, current guidelines no more favour the uses of sulphonylureas for CV safety concern, except when cost is an issue. However, formal cardiovascular outcome trial (CVOT) is not available. MATERIALS AND METHODS: We performed an indirect...
Autores principales: | Ghosh, Sujoy, Mukhopadhyay, Pradip, Pandey, Prabhakar, Chatterjee, Purushottam, Pandit, Kaushik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919221/ https://www.ncbi.nlm.nih.gov/pubmed/33213193 http://dx.doi.org/10.1177/1479164120973653 |
Ejemplares similares
-
Lipid Profile in Infant
por: Kumar, Ashok, et al.
Publicado: (2021) -
Uric Acid and Its Correlation with Various Metabolic Parameters: A Population-Based Study
por: Mukhopadhyay, Pradip, et al.
Publicado: (2019) -
Pandemic of Vitamin D Deficiency: Cardiometabolic Concern or Skeletal Biochemical Abnormality?
por: Mukhopadhyay, Pradip, et al.
Publicado: (2019) -
Natriuretic peptides: Diagnostic and therapeutic use
por: Pandit, Kaushik, et al.
Publicado: (2011) -
Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA(®))
por: Marx, Nikolaus, et al.
Publicado: (2015)